1,185
Views
151
CrossRef citations to date
0
Altmetric
Growth Factor Signaling and Radiotherapy to Encompass Both EGFR and TGFβ

Radiation-induced EGFR-signaling and control of DNA-damage repair

, &
Pages 781-791 | Received 07 Aug 2007, Accepted 25 Oct 2007, Published online: 03 Jul 2009

References

  • Ang K K, Berkey B A, Tu X, Zhang H Z, Katz R, Hammond E H, Fu K K, Milas L. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Research 2002; 62: 7350–7356
  • Bandyopadhyay D, Mandal M, Adam L, Mendelsohn J, Kumar R. Physical interaction between epidermal growth factor receptor and DNA-dependent protein kinase in mammalian cells. Journal of Biological Chemistry 1998; 273: 1568–1573
  • Barker F G, 2nd, Simmons M L, Chang S M, Prados M D, Larson D A, Sneed P K, Wara W M, Berger M S, Chen P, Israel M A, Aldape K D. EGFR overexpression and radiation response in glioblastoma multiforme. International Journal of Radiation Oncology, Biology and Physics 2001; 51: 410–418
  • Baumann M, Krause M, Dikomey E, Dittmann K, Doerr W, Kasten-Pisula U, Rodemann H P. EGFR-targeted anti-cancer drugs in radiotherapy: Preclinical evaluation of mechanisms. Radiotherapy and Oncology 2007; 83: 238–248
  • Berclaz G, Altermatt H J, Rohrbach V, Siragusa A, Dreher E, Smith P D. EGFR dependent expression of STAT3 (but not STAT1) in breast cancer. International Journal of Oncology 2001; 19: 1155–1160
  • Bernhard E J, Stanbridge E J, Gupta S, Gupta A K, Soto D, Bakanauskas V J, Cerniglia G J, Muschel R J, McKenna W G. Direct evidence for the contribution of activated N-ras and K-ras oncogenes to increased intrinsic radiation resistance in human tumor cell lines. Cancer Research 2000; 60: 6597–6600
  • Burke P, Schooler K, Wiley H S. Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking. Molecular Biology of the Cell 2001; 12: 1897–1910
  • Carpenter G. Nuclear localization and possible functions of receptor tyrosine kinases. Current Opinion in Cell Biology 2003; 15: 143–148
  • Cengel K A, Voong K R, Chandrasekaran S, Maggiorella L, Brunner T B, Stanbridge E, Kao G D, McKenna W G, Bernhard E J. Oncogenic K-Ras signals through epidermal growth factor receptor and wild-type H-Ras to promote radiation survival in pancreatic and colorectal carcinoma cells. Neoplasia 2007; 9: 341–348
  • Cespedes M V, Sancho F J, Guerrero S, Parreno M, Casanova I, Pavon M A, Marcuello E, Trias M, Cascante M, Capella G, Mangues R. K-ras Asp12 mutant neither interacts with Raf, nor signals through Erk and is less tumorigenic than K-ras Val12. Carcinogenesis 2006; 27: 2190–2200
  • Chan D W, Chen B P, Prithivirajsingh S, Kurimasa A, Story M D, Qin J, Chen D J. Autophosphorylation of the DNA-dependent protein kinase catalytic subunit is required for rejoining of DNA double-strand breaks. Genes & Development 2002; 16: 2333–2338
  • Chattopadhyay A, Vecchi M, Ji Q, Mernaugh R, Carpenter G. The role of individual SH2 domains in mediating association of phospholipase C-gamma1 with the activated EGF receptor. Journal of Biological Chemistry 1999; 274: 26091–26097
  • Chen B P, Uematsu N, Kobayashi J, Lerenthal Y, Krempler A, Yajima H, Lobrich M, Shiloh Y, Chen D J. Ataxia telangiectasia mutated (ATM) is essential for DNA-PKcs phosphorylations at the Thr-2609 cluster upon DNA double strand break. Journal of Biological Chemistry 2007; 282: 6582–6587
  • Cohen S, Ushiro H, Stoscheck C, Chinkers M. A native 170,000 epidermal growth factor receptor-kinase complex from shed plasma membrane vesicles. Journal of Biological Chemistry 1982; 257: 1523–1531
  • Coqueret O. New roles for p21 and p27 cell-cycle inhibitors: A function for each cell compartment?. Trends in Cell Biology 2003; 13: 65–70
  • Das A K, Chen B P, Story M D, Sato M, Minna J D, Chen D J, Nirodi C S. Somatic mutations in the tyrosine kinase domain of epidermal growth factor receptor (EGFR) abrogate EGFR-mediated radioprotection in non-small cell lung carcinoma. Cancer Research 2007; 67: 5267–5274
  • Dent P, Yacoub A, Contessa J, Caron R, Amorino G, Valerie K, Hagan M P, Grant S, Schmidt-Ullrich R. Stress and radiation-induced activation of multiple intracellular signaling pathways. Radiation Research 2003; 159: 283–300
  • Dikic I. Mechanisms controlling EGF receptor endocytosis and degradation. Biochemical Society Transactions 2003; 31: 1178–1181
  • Dittmann K, Mayer C, Fehrenbacher B, Schaller M, Raju U, Milas L, Chen D J, Kehlbach R, Rodemann H P. Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase. Journal of Biological Chemistry 2005a; 280: 31182–31189
  • Dittmann K, Mayer C, Rodemann H P. Inhibition of radiation-induced EGFR nuclear import by C225 (Cetuximab) suppresses DNA-PK activity. Radiotherapy & Oncology 2005b; 76: 157–161
  • Eke I, Sandfort V, Mischkus A, Baumann M, Cordes N. Antiproliferative effects of EGFR tyrosine kinase inhibition and radiation-induced genotoxic injury are attenuated by adhesion to fibronectin. Radiotherapy & Oncology 2006; 80: 178–184
  • Fiano V, Ghimenti C, Imarisio S, Silengo L, Schiffer D. PAkt, cyclin D1 and p27/Kip.1 in glioblastomas with and without EGFR amplification and PTEN mutation. Anticancer Research 2004; 24: 2643–2647
  • Fleming J B, Shen G L, Holloway S E, Davis M, Brekken R A. Molecular consequences of silencing mutant K-ras in pancreatic cancer cells: justification for K-ras-directed therapy. Molecular Cancer Research 2005; 3: 413–423
  • Fortini P, Dogliotti E. Base damage and single-strand break repair: Mechanisms and functional significance of short- and long-patch repair subpathways. DNA Repair (Amst) 2007; 6: 398–409
  • Friedmann B J, Caplin M, Savic B, Shah T, Lord C J, Ashworth A, Hartley J A, Hochhauser D. Interaction of the epidermal growth factor receptor and the DNA-dependent protein kinase pathway following gefitinib treatment. Molecular Cancer Therapeutics 2006; 5: 209–218
  • Gangarosa L M, Sizemore N, Graves-Deal R, Oldham S M, Der C J, Coffey R J. A raf-independent epidermal growth factor receptor autocrine loop is necessary for Ras transformation of rat intestinal epithelial cells. Journal of Biological Chemistry 1997; 272: 18926–18931
  • Geng L, Tan J, Himmelfarb E, Schueneman A, Niermann K, Brousal J, Fu A, Cuneo K, Kesicki E A, Treiberg J, Hayflick J S, Hallahan D E. A specific antagonist of the p110delta catalytic component of phosphatidylinositol 3′-kinase, IC486068, enhances radiation-induced tumor vascular destruction. Cancer Research 2004; 64: 4893–4899
  • Giri D K, Ali-Seyed M, Li L Y, Lee D F, Ling P, Bartholomeusz G, Wang S C, Hung M C. Endosomal transport of ErbB-2: Mechanism for nuclear entry of the cell surface receptor. Molecular Cell Biology 2005; 25: 11005–11018
  • Gullick W J, Downward J, Parker P J, Whittle N, Kris R, Schlessinger J, Ullrich A, Waterfield M D. The structure and function of the epidermal growth factor receptor studied by using antisynthetic peptide antibodies. Proceedings of the Royal Society London B: Biological Sciences 1985; 226: 127–134
  • Gupta A K, Bakanauskas V J, Cerniglia G J, Cheng Y, Bernhard E J, Muschel R J, McKenna W G. The Ras radiation resistance pathway. Cancer Research 2001; 61: 4278–4282
  • Gupta A K, McKenna W G, Weber C N, Feldman M D, Goldsmith J D, Mick R, Machtay M, Rosenthal D I, Bakanauskas V J, Cerniglia G J, Bernhard E J, Weber R S, Muschel R J. Local recurrence in head and neck cancer: Relationship to radiation resistance and signal transduction. Clinical Cancer Research 2002; 8: 885–892
  • Hanada N, Lo H W, Day C P, Pan Y, Nakajima Y, Hung M C. Co-regulation of B-Myb expression by E2F1 and EGF receptor. Molecular Carcinogenesis 2006; 45: 10–17
  • Hatakeyama M, Yumoto N, Yu X, Shirouzu M, Yokoyama S, Konagaya A. Transformation potency of ErbB heterodimer signaling is determined by B-Raf kinase. Oncogene 2004; 23: 5023–5031
  • Huang S M, Harari P M. Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: Inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis. Clinical Cancer Research 2000; 6: 2166–2174
  • Huang S M, Li J, Harari P M. Molecular inhibition of angiogenesis and metastatic potential in human squamous cell carcinomas after epidermal growth factor receptor blockade. Molecular Cancer Therapeutics 2002; 1: 507–514
  • Ikeda S, Takabe K, Inagaki M, Funakoshi N, Suzuki K, Shibata T. Correlation between EGFR gene mutation pattern and Akt phosphorylation in pulmonary adenocarcinomas. Pathology International 2007; 57: 268–275
  • Kasten U, Plottner N, Johansen J, Overgaard J, Dikomey E. Ku70/80 gene expression and DNA-dependent protein kinase (DNA-PK) activity do not correlate with double-strand break (dsb) repair capacity and cellular radiosensitivity in normal human fibroblasts. British Journal of Cancer 1999; 79: 1037–1041
  • Kasten-Pisula U, Tastan H, Dikomey E. Huge differences in cellular radiosensitivity due to only very small variations in double-strand break repair capacity. International Journal of Radiation Biology 2005; 81: 409–419
  • Khan E M, Heidinger J M, Levy M, Lisanti M P, Ravid T, Goldkorn T. Epidermal growth factor receptor exposed to oxidative stress undergoes Src- and caveolin-1-dependent perinuclear trafficking. Journal of Biological Chemistry 2006; 281: 14486–14493
  • Kim H H, Sierke S L, Koland J G. Epidermal growth factor-dependent association of phosphatidylinositol 3-kinase with the erbB3 gene product. Journal Biological Chemistry 1994; 269: 24747–24755
  • Kim T J, Lee J W, Song S Y, Choi J J, Choi C H, Kim B G, Lee J H, Bae D S. Increased expression of pAKT is associated with radiation resistance in cervical cancer. British Journal of Cancer 2006; 94: 1678–1682
  • Krause M, Prager J, Zhou X, Yaromina A, Dorfler A, Eicheler W, Baumann M. EGFR-TK inhibition before radiotherapy reduces tumour volume but does not improve local control: Differential response of cancer stem cells and nontumourigenic cells?. Radiotherapy & Oncology 2007; 83: 316–325
  • Krause M, Zips D, Thames H D, Kummermehr J, Baumann M. Preclinical evaluation of molecular-targeted anticancer agents for radiotherapy. Radiotherapy & Oncology 2006; 80: 112–122
  • Kumar P, Benedict R, Urzua F, Fischbach C, Mooney D, Polverini P. Combination treatment significantly enhances the efficacy of antitumor therapy by preferentially targeting angiogenesis. Laboratory Investigation 2005; 85: 756–767
  • Lassmann S, Schuster I, Walch A, Gobel H, Jutting U, Makowiec F, Hopt U, Werner M. STAT3 mRNA and protein expression in colorectal cancer: Effects on STAT3-inducible targets linked to cell survival and proliferation. Journal of Clinical Pathology 2007; 60: 173–179
  • Lin S Y, Makino K, Xia W, Matin A, Wen Y, Kwong K Y, Bourguignon L, Hung M C. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nature Cell Biology 2001; 3: 802–808
  • Ljungdahl S, Linder S, Sollerbrant K, Svensson C, Shoshan M C. Signal transduction in fibroblasts stably transformed by [Val12]Ras – the activities of extracellular-signal-regulated kinase and Jun N-terminal kinase are only moderately increased, and the activity of the delta-inhibitor of c-Jun is not alleviated. European Journal of Biochemistry 1997; 249: 648–656
  • Lo H W, Ali-Seyed M, Wu Y, Bartholomeusz G, Hsu S C, Hung M C. Nuclear-cytoplasmic transport of EGFR involves receptor endocytosis, importin beta1 and CRM1. Journal of Cellular Biochemistry 2006; 98: 1570–1583
  • Lo H W, Hsu S C, Ali-Seyed M, Gunduz M, Xia W, Wei Y, Bartholomeusz G, Shih J Y, Hung M C. Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway. Cancer Cell 2005; 7: 575–589
  • Lo H W, Hung M C. Nuclear EGFR signaling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival. British Journal of Cancer 2007; 96(Suppl.)R16–20
  • Martinez-Lacaci I, Kannan S, De Santis M, Bianco C, Kim N, Wallace-Jones B, Ebert A D, Wechselberger C, Salomon D S. RAS transformation causes sustained activation of epidermal growth factor receptor and elevation of mitogen-activated protein kinase in human mammary epithelial cells. International Journal of Cancer 2000; 88: 44–52
  • McKenna W G, Muschel R J, Gupta A K, Hahn S M, Bernhard E J. The RAS signal transduction pathway and its role in radiation sensitivity. Oncogene 2003; 22: 5866–5875
  • Min Y H, Cheong J W, Kim J Y, Eom J I, Lee S T, Hahn J S, Ko Y W, Lee M H. Cytoplasmic mislocalization of p27Kip1 protein is associated with constitutive phosphorylation of Akt or protein kinase B and poor prognosis in acute myelogenous leukemia. Cancer Research 2004; 64: 5225–5231
  • Nabi I R, Le P U. Caveolae/raft-dependent endocytosis. Journal of Cell Biology 2003; 161: 673–677
  • Nakamura J L. The epidermal growth factor receptor in malignant gliomas: pathogenesis and therapeutic implications. Expert Opinion on Therapeutic Targets 2007; 11: 463–472
  • Ni C Y, Murphy M P, Golde T E, Carpenter G. gamma-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science 2001; 294: 2179–2181
  • Nicholson K M, Anderson N G. The protein kinase B/Akt signaling pathway in human malignancy. Cell Signaling 2002; 14: 381–395
  • Nyati M K, Morgan M A, Feng F Y, Lawrence T S. Integration of EGFR inhibitors with radiochemotherapy. Nature Reviews Cancer 2006; 6: 876–885
  • O'Connor R. Survival factors and apoptosis. Adv Biochem Eng Biotechnol 1998; 62: 137–166
  • Offterdinger M, Schofer C, Weipoltshammer K, Grunt T W. c-erbB-3: A nuclear protein in mammary epithelial cells. Journal of Cell Biology 2002; 157: 929–939
  • Park C M, Park M J, Kwak H J, Lee H C, Kim M S, Lee S H, Park I C, Rhee C H, Hong S I. Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and Phosphatidylinositol 3-Kinase/Akt signaling pathways. Cancer Research 2006; 66: 8511–8519
  • Park M J, Kwak H J, Lee H C, Yoo D H, Park I C, Kim M S, Lee S H, Rhee C H, Hong S I. Nerve growth factor induces endothelial cell invasion and cord formation by promoting matrix metalloproteinase-2 expression through the phosphatidylinositol-3 kinase/AKT signaling pathway and AP-2 transcription factor. Journal of Biological Chemistry 2007; 282: 30485 – 30496.
  • Purschke M, Kasten-Pisula U, Brammer I, Dikomey E. Human and rodent cell lines showing no differences in the induction but differing in the repair kinetics of radiation-induced DNA base damage. International Journal of Radiation Biology 2004; 80: 29–38
  • Ravid T, Sweeney C, Gee P, Carraway K L, 3rd, Goldkorn T. Epidermal growth factor receptor activation under oxidative stress fails to promote c-Cbl mediated down-regulation. Journal of Biological Chemistry 2002; 277: 31214–31219
  • Schmidt-Ullrich R K, Mikkelsen R B, Dent P, Todd D G, Valerie K, Kavanagh B D, Contessa J N, Rorrer W K, Chen P B. Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation. Oncogene 1997; 15: 1191–1197
  • Shin I, Rotty J, Wu F Y, Arteaga C L. Phosphorylation of p27Kip1 at Thr-157 interferes with its association with importin alpha during G1 and prevents nuclear re-entry. Journal of Biological Chemistry 2005; 280: 6055–6063
  • Sizemore N, Cox A D, Barnard J A, Oldham S M, Reynolds E R, Der C J, Coffey R J. Pharmacological inhibition of Ras-transformed epithelial cell growth is linked to down-regulation of epidermal growth factor-related peptides. Gastroenterology 1999; 117: 567–576
  • Soltoff S P, Carraway K L, Prigent S A, Gullick W G, Cantley L C. ErbB3 is involved in activation of phosphatidylinositol-3-kinase by epidermal growth factor. Molecular and Cellular Biology 1994; 14: 3550–3558
  • Song G, Ouyang G, Bao S. The activation of Akt/PKB signaling pathway and cell survival. Journal of Cellular & Molecular Medicine 2005; 9: 59–71
  • Sorkin A. Internalization of the epidermal growth factor receptor: role in signaling. Biochemical Society Transactions 2001; 29: 480–484
  • Stover D R, Becker M, Liebetanz J, Lydon N B. Src phosphorylation of the epidermal growth factor receptor at novel sites mediates receptor interaction with Src and P85 alpha. Journal of Biological Chemistry 1995; 270: 15591–15597
  • Tokunaga E, Kataoka A, Kimura Y, Oki E, Mashino K, Nishida K, Koga T, Morita M, Kakeji Y, Baba H, Ohno S, Maehara Y. The association between Akt activation and resistance to hormone therapy in metastatic breast cancer. European Journal of Cancer 2006; 42: 629–635
  • Toledano-Katchalski H, Kraut J, Sines T, Granot-Attas S, Shohat G, Gil-Henn H, Yung Y, Elson A. Protein tyrosine phosphatase epsilon inhibits signaling by mitogen-activated protein kinases. Molecular Cancer Research 2003; 1: 541–550
  • Toulany M, Dittmann K, Baumann M, Rodemann H P. Radiosensitization of Ras-mutated human tumor cells in vitro by the specific EGF receptor antagonist BIBX1382BS. Radiotherapy & Oncology 2005a; 74: 117–129
  • Toulany M, Dittmann K, Kruger M, Baumann M, Rodemann H P. Radioresistance of K-Ras mutated human tumor cells is mediated through EGFR-dependent activation of PI3K-AKT pathway. Radiotherapy & Oncology 2005b; 76: 143–150
  • Toulany M, Kasten-Pisula U, Brammer I, Wang S, Chen J, Dittmann K, Baumann M, Dikomey E, Rodemann H P. Blockage of epidermal growth factor receptor-phosphatidylinositol 3-kinase-AKT signaling increases radiosensitivity of K-RAS mutated human tumor cells in vitro by affecting DNA repair. Clinical Cancer Research 2006; 12: 4119–4126
  • Toulany M, Baumann M, Rodemann H P. Stimulated PI3K-AKT signaling mediated through ligand or radiation-induced EGFR depends indirectly, but not directly, on constitutive K-Ras activity. Molecular Cancer Research 2007; 5: 863–872
  • Uematsu N, Weterings E, Yano K, Morotomi-Yano K, Jakob B, Taucher-Scholz G, Mari P O, van Gent D C, Chen B P, Chen D J. Autophosphorylation of DNA-PKCS regulates its dynamics at DNA double-strand breaks. Journal of Cell Biology 2007; 177: 219–229
  • Viniegra J G, Martinez N, Modirassari P, Losa J H, Parada Cobo C, Lobo V J, Luquero C I, Alvarez-Vallina L, Ramon y Cajal S, Rojas J M, Sanchez-Prieto R. Full activation of PKB/Akt in response to insulin or ionizing radiation is mediated through ATM. Journal of Biological Chemistry 2005; 280: 4029–4036
  • Wang M, Wu W, Rosidi B, Zhang L, Wang H, Iliakis G. PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways. Nucleic Acids Research 2006a; 34: 6170–6182
  • Wang Q, Villeneuve G, Wang Z. Control of epidermal growth factor receptor endocytosis by receptor dimerization, rather than receptor kinase activation. The EMBO Reports 2005; 6: 942–948
  • Wang S C, Lien H C, Xia W, Chen I F, Lo H W, Wang Z, Ali-Seyed M, Lee D F, Bartholomeusz G, Ou-Yang F, Giri D K, Hung M C. Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2. Cancer Cell 2004; 6: 251–261
  • Wang S C, Nakajima Y, Yu Y L, Xia W, Chen C T, Yang C C, McIntush E W, Li L Y, Hawke D H, Kobayashi R, Hung M C. Tyrosine phosphorylation controls PCNA function through protein stability. Nature Cell Biology 2006b; 8: 1359–1368
  • Waterman H, Yarden Y. Molecular mechanisms underlying endocytosis and sorting of ErbB receptor tyrosine kinases. FEBS Letters 2001; 490: 142–152
  • Waters S B, Chen D, Kao A W, Okada S, Holt K H, Pessin J E. Insulin and epidermal growth factor receptors regulate distinct pools of Grb2-SOS in the control of Ras activation. Journal of Biological Chemistry 1996; 271: 18224–18230
  • Wieman H L, Wofford J A, Rathmell J C. Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase/Akt regulation of Glut1 activity and trafficking. Molecular Biology of the Cell 2007; 18: 1437–1446
  • Xia L, Wang L, Chung A S, Ivanov S S, Ling M Y, Dragoi A M, Platt A, Gilmer T M, Fu X Y, Chin Y E. Identification of both positive and negative domains within the epidermal growth factor receptor COOH-terminal region for signal transducer and activator of transcription (STAT) activation. Journal of Biological Chemistry 2002; 277: 30716–30723
  • Xie Y, Hung M C. Nuclear localization of p185neu tyrosine kinase and its association with transcriptional transactivation. Biochemical & Biophysical Research Communications 1994; 203: 1589–1598
  • Xing D, Orsulic S. A genetically defined mouse ovarian carcinoma model for the molecular characterization of pathway-targeted therapy and tumor resistance. Proceedings of the National Academy of Sciences USA 2005; 102: 6936–6941
  • Yacoub A, McKinstry R, Hinman D, Chung T, Dent P, Hagan M P. Epidermal growth factor and ionizing radiation up-regulate the DNA repair genes XRCC1 and ERCC1 in DU145 and LNCaP prostate carcinoma through MAPK signaling. Radiation Research 2003; 159: 439–452
  • Yacoub A, Miller A, Caron R W, Qiao L, Curiel D A, Fisher P B, Hagan M P, Grant S, Dent P. Radiotherapy-induced signal transduction. Endocrine-Related Cancer 2006; 13(Suppl. 1)S99–114
  • Yacoub A, Park J S, Qiao L, Dent P, Hagan M P. MAPK dependence of DNA damage repair: ionizing radiation and the induction of expression of the DNA repair genes XRCC1 and ERCC1 in DU145 human prostate carcinoma cells in a MEK1/2 dependent fashion. International Journal of Radiation Biology 2001; 77: 1067–1078
  • Yamasaki F, Johansen M J, Zhang D, Krishnamurthy S, Felix E, Bartholomeusz C, Aguilar R J, Kurisu K, Mills G B, Hortobagyi G N, Ueno N T. Acquired resistance to erlotinib in A-431 epidermoid cancer cells requires down-regulation of MMAC1/PTEN and up-regulation of phosphorylated Akt. Cancer Research 2007; 67: 5779–5788
  • Yang S H, Jaffray E, Hay R T, Sharrocks A D. Dynamic interplay of the SUMO and ERK pathways in regulating Elk-1 transcriptional activity. Molecular Cell 2003; 12: 63–74
  • Yarden Y. The EGFR family and its ligands in human cancer. Signaling mechanisms and therapeutic opportunities. European Journal of Cancer 2001; 37(Suppl. 4)S3–8
  • Yokoyama H, Ikehara Y, Kodera Y, Ikehara S, Yatabe Y, Mochizuki Y, Koike M, Fujiwara M, Nakao A, Tatematsu M, Nakanishi H. Molecular basis for sensitivity and acquired resistance to gefitinib in HER2-overexpressing human gastric cancer cell lines derived from liver metastasis. British Journal of Cancer 2006; 95: 1504–1513
  • Zhang J, Lodish H F. Identification of K-ras as the major regulator for cytokine-dependent Akt activation in erythroid progenitors in vivo. Proceedings of the National Academy of Sciences USA 2005; 102: 14605–14610

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.